Bicycle Therapeutics plc (BCYC) Misses Q2 EPS by 15c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q2 EPS of ($0.72), $0.15 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $630 thousand versus the consensus estimate of $4.35 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
• Clariant AG (CLN:SW) (CLZNY) PT Raised to CHF13 at JPMorgan